Generic Name: Rocaltrol

What is Rocaltrol?

There may be an interaction between calcitriol and any of the following: cholestyramine colestipol digoxin magnesium supplements or antacids mineral oil laxatives phenobarbital phenytoin phosphate vitamin D If you are taking any of these medications, speak with your doctor or pharmacist. Depending on your specific circumstances, your doctor may want you to: stop taking one of the medications, change one of the medications to another, change how you are taking one or both of the medications, or leave everything as is.

You can now update your password. What side effects are possible with this medication. DIN Drug Information Number 00481823 ROCALTROL 0.

See Prescriptions for more details. Please contact our pharmacist for more information. If you order this item as Private, NO PBS stickers will be issued.

Tell your doctor about all medications you use. This includes prescription, over-the-counter, vitamin, and herbal products. Do not start a new medication without telling your doctor. Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Inc. Drug information contained herein may be time sensitive. Multum information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Multum does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise.

Multum's drug information does not endorse drugs, diagnose patients or recommend therapy. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient.

Multum does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects.

If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist. The above information is provided for general informational and educational purposes only. Individual plans may vary and formulary information changes. Contact the applicable plan provider for the most current information. To: By clicking send, you acknowledge that you have permission to email the recipient with this information.

How should I take Rocaltrol?

Download Iodine for iPhoneDownload Start for iPhoneDownload Start for Android. Dosing: Hypoparathyroid Patients - Predialysis Patients- Dialysis patients- Hypoparathyroid patients Dosing and Administration The optimal daily dose of Rocaltrol must be carefully determined for each patient. Most adult patients have responded to dosages in the range of 0. Dosing guidelines have not been established for pediatric patients under 1 year of age with hypoparathyroidism The number of treated patients with pseudohypoparathyroidism less than 6 years of age is too small to make dosage recommendations.

If hypercalcemia develops in a patient receiving Rocaltrol, treatment should be immediately discontinued. In treating chronic hypocalcemia and resultant metabolic bone disease in patients undergoing chronic dialysis, the optimal dose must be carefully determined for each patient.

What should I avoid while taking Rocaltrol?

Because many drugs are excreted in human milk and because of the potential for serious adverse reactions from Rocaltrol calcitriol in nursing infants, a mother should not nurse while taking Rocaltrol calcitriol. Safety and effectiveness of Rocaltrol calcitriol in pediatric patients undergoing dialysis have not been established. The safety and effectiveness of Rocaltrol calcitriol in pediatric predialysis patients is based on evidence from adequate and well-controlled studies of Rocaltrol calcitriol in adults with predialysis chronic renal failure and additional supportive data from non-placebo controlled studies in pediatric patients.

Long-term calcitriol therapy is well tolerated by pediatric patients. The most common safety issues are mild, transient episodes of hypercalcemia, hyperphosphatemia, and increases in the serum calcium times phosphate Ca x P product which are managed effectively by dosage adjustment or temporary discontinuation of the vitamin D derivative.

Rocaltrol side effects

La dose giornaliera ottimale di Rocaltrol va stabilita accuratamente in ogni paziente sulla base dei valori della calcemia. Se dopo 2-4 settimane non si osservano miglioramenti del quadro clinico e dei parametri biochimici, la dose di Rocaltrol va aumentata di 0,25 mcg al giorno ad intervalli di 2-4 settimane.

Durante questo intervallo, la calcemia va determinata almeno 2 volte la settimana. Nel rachitismo ipofosfatemico vitamina D-resistente la somministrazione di Rocaltrol porta ad un miglioramento del quadro clinico e ad una normalizzazione dei fosfati circolanti. Nel rachitismo familiare vitamina D-pseudodipendente Rocaltrol determina la remissione delle lesioni ossee e la normalizzazione dei valori calcemici e fosfatemici e dell'assorbimento intestinale di calcio.

Common Rocaltrol ide effects may include:

  • Do not take it in larger amounts or for longer than recommended.

  • Medications other than those listed above may interact with this medication.

  • Dialysis Patients Rocaltrol is indicated in the management of hypocalcemia and the resultant metabolic bone disease in patients undergoing chronic renal dialysis.

  • Rocaltrol is also indicated in the management of hypocalcemia and its clinical manifestations in patients with postsurgical hypoparathyroidism, idiopathic hypoparathyroidism, and pseudohypoparathyroidism.

Serum calcium levels should be determined 1 week after withdrawal of calcium supplements. If serum calcium levels have returned to normal, Rocaltrol calcitriol therapy may be reinstituted at a dosage of 0.

If Rocaltrol calcitriol therapy was previously administered at a dosage of 0. If hypercalcemia is persistent at the reduced dosage, serum PTH should be measured. If serum PTH is normal, discontinue Rocaltrol calcitriol therapy and monitor patient in 3 months' time.

More about Rocaltrol

Consumer resources

Other brands:Order shigru

Professional resources

Where can I get more information?

  • Patients with normal renal function who are taking Rocaltrol should avoid dehydration.

  • Dosing: Hypoparathyroid Patients - Predialysis Patients- Dialysis patients- Hypoparathyroid patients Dosing and Administration The optimal daily dose of Rocaltrol must be carefully determined for each patient.